Triamterene/hydrochlorothiazide

— THERAPEUTIC CATEGORIES —
  • Edema
  • Hypertension

Triamterene/hydrochlorothiazide Generic Name & Formulations

General Description

Triamterene 37.5mg, hydrochlorothiazide 25mg; caps.

Pharmacological Class

Diuretic (K+ sparing) + (thiazide).

How Supplied

Contact supplier

Triamterene/hydrochlorothiazide Indications

Indications

Edema.

Triamterene/hydrochlorothiazide Dosage and Administration

Adult

1–2 caps once daily.

Children

Not established.

Triamterene/hydrochlorothiazide Contraindications

Contraindications

Hyperkalemia. Renal impairment. Anuria. Sulfonamide allergy. Concomitant potassium or K+-sparing diuretics.

Triamterene/hydrochlorothiazide Boxed Warnings

Boxed Warning

Hyperkalemia.

Triamterene/hydrochlorothiazide Warnings/Precautions

Warnings/Precautions

Risk of hyperkalemia; monitor frequently. Discontinue if serum potassium >5.5mEq/L or <3mEq/L. Diabetes. Acidosis predisposition. Electrolyte imbalance. Hypochloremia with metabolic alkalosis. Excess diuresis. History of renal stones. Gout. Surgery. SLE. Monitor electrolytes, renal function. Hepatic impairment: monitor for hepatic coma, if confusion increases, discontinue for a few days. Severely ill. Elderly. Pregnancy. Nursing mothers: not recommended.

Triamterene/hydrochlorothiazide Pharmacokinetics

See Literature

Triamterene/hydrochlorothiazide Interactions

Interactions

Digoxin, lithium toxicity. Hyperkalemia more likely with ACE inhibitors, parenteral penicillin G. Hypokalemia with ACTH, corticosteroids, amphotericin B. Hyponatremia with sulfonylureas. NSAIDs may cause renal failure. Adjust antidiabetic, antigout medications. May potentiate nondepolarizing muscle relaxants, antihypertensives. Antagonizes oral anticoagulants, methenamine. May interfere with parathyroid tests.

Triamterene/hydrochlorothiazide Adverse Reactions

Adverse Reactions

Drowsiness, muscle cramps, weakness, headache, GI disturbances, dizziness, impotence, arrhythmias, hypotension, dry mouth, urine discoloration; HCTZ: increased risk for non-melanoma skin cancer.

Triamterene/hydrochlorothiazide Clinical Trials

See Literature

Triamterene/hydrochlorothiazide Note

Notes

Formerly known under the brand name Dyazide.

Triamterene/hydrochlorothiazide Patient Counseling

See Literature

Triamterene/hydrochlorothiazide Generic Name & Formulations

General Description

Triamterene 37.5mg, hydrochlorothiazide 25mg; caps.

Pharmacological Class

Diuretic (K+ sparing) + (thiazide).

How Supplied

Contact supplier

Triamterene/hydrochlorothiazide Indications

Indications

Hypertension when normokalemia is essential.

Triamterene/hydrochlorothiazide Dosage and Administration

Adult

1–2 caps once daily.

Children

Not established.

Triamterene/hydrochlorothiazide Contraindications

Contraindications

Hyperkalemia. Renal impairment. Anuria. Sulfonamide allergy. Concomitant potassium or K+-sparing diuretics.

Triamterene/hydrochlorothiazide Boxed Warnings

Boxed Warning

Hyperkalemia.

Triamterene/hydrochlorothiazide Warnings/Precautions

Warnings/Precautions

Risk of hyperkalemia; monitor frequently. Discontinue if serum potassium >5.5mEq/L or <3mEq/L. Diabetes. Acidosis predisposition. Electrolyte imbalance. Hypochloremia with metabolic alkalosis. Excess diuresis. History of renal stones. Gout. Surgery. SLE. Monitor electrolytes, renal function. Hepatic impairment: monitor for hepatic coma, if confusion increases, discontinue for a few days. Severely ill. Elderly. Pregnancy. Nursing mothers: not recommended.

Triamterene/hydrochlorothiazide Pharmacokinetics

See Literature

Triamterene/hydrochlorothiazide Interactions

Interactions

Digoxin, lithium toxicity. Hyperkalemia more likely with ACE inhibitors, parenteral penicillin G. Hypokalemia with ACTH, corticosteroids, amphotericin B. Hyponatremia with sulfonylureas. NSAIDs may cause renal failure. Adjust antidiabetic, antigout medications. May potentiate nondepolarizing muscle relaxants, antihypertensives. Antagonizes oral anticoagulants, methenamine. May interfere with parathyroid tests.

Triamterene/hydrochlorothiazide Adverse Reactions

Adverse Reactions

Drowsiness, muscle cramps, weakness, headache, GI disturbances, dizziness, impotence, arrhythmias, hypotension, dry mouth, urine discoloration; HCTZ: increased risk for non-melanoma skin cancer.

Triamterene/hydrochlorothiazide Clinical Trials

See Literature

Triamterene/hydrochlorothiazide Note

Notes

Formerly known under the brand name Dyazide.

Triamterene/hydrochlorothiazide Patient Counseling

See Literature